Methyl 6-oxo-1,6-dihydropyridazine-3-carboxylate

Introduction

CAS No. :	63001-30-9	MDL No. :	MFCD17015975
Formula :	C6H6N2O3	Boiling Point :	No data available
Linear Structure Formula :	-	InChI Key :	REYKVZJYIFOXTI-UHFFFAOYSA-N
M.W :	154.12	Pubchem ID :	9124994
Synonyms :

Physicochemical Properties

Num. heavy atoms :	11
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.17
Num. rotatable bonds :	2
Num. H-bond acceptors :	4.0
Num. H-bond donors :	1.0
Molar Refractivity :	36.14
TPSA :	72.05 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-7.55 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.06
Log Po/w (XLOGP3) :	-0.44
Log Po/w (WLOGP) :	-0.44
Log Po/w (MLOGP) :	-0.17
Log Po/w (SILICOS-IT) :	0.88
Consensus Log Po/w :	0.18

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-0.79
Solubility :	25.0 mg/ml ; 0.162 mol/l
Class :	Very soluble
Log S (Ali) :	-0.61
Solubility :	38.0 mg/ml ; 0.247 mol/l
Class :	Very soluble
Log S (SILICOS-IT) :	-1.62
Solubility :	3.7 mg/ml ; 0.024 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.72

Signal Word:	Warning	Class:
Precautionary Statements:	P261-P280-P305+P351+P338	UN#:
Hazard Statements:	H302-H315-H319-H332-H335	Packing Group:
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine